CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García, I.
Right arrow Articles by Zubiaga, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García, I.
Right arrow Articles by Zubiaga, A. M.
Cell Growth & Differentiation Vol. 11, 91-98, February 2000
© 2000 American Association for Cancer Research

Articles

A Role for E2F1 in the Induction of Apoptosis during Thymic Negative Selection1

Itxaso García, Matilde Murga, Alberto Vicario, Seth J. Field2 and Ana M. Zubiaga3

Department of Animal Biology and Genetics, Faculty of Sciences, University of the Basque Country, E-48080, Spain [I. G., M. M., A. V., A. M. Z.], and Children’s Hospital, Department of Neuroscience, Harvard Medical School, Boston, Massachusetts 02115 [S. J. F.]

Abstract

Thymic negative selection is the process in which maturing thymocytes that express T-cell receptors recognizing self are eliminated by apoptotic cell death. The molecular mechanism by which this occurs is poorly understood. Notably, genes involved in cell death, even thymocyte death, such as Fas, Fas-ligand, p53, caspase-1, caspase-3, and caspase-9, and Bcl-2 have been found to not be required for normal thymic negative selection. We have demonstrated previously that E2F1-deficient mice have a defect in thymocyte apoptosis. Here we show that E2F1 is required for normal thymic negative selection. Furthermore, we observed an E2F1-dependent increase of p53 protein levels during the process of thymic clonal deletion, which suggests that E2F1 regulates activation-induced apoptosis of self-reactive thymocytes by a p53-dependent mechanism. In contrast, other apoptotic pathways operating on developing thymocytes, such as glucocorticoid-induced cell death, are not mediated by E2F1. The T lymphocytes that escape thymic negative selection migrate to the peripheral immune system but do not appear to be autoreactive, indicating that there may exist E2F1-independent mechanisms of peripheral tolerance, which protect mice from developing an autoimmune response. We expect that E2F1-deficient mice will provide a useful tool for understanding the molecular mechanism of and the immunological importance of thymic negative selection.




This article has been cited by other articles:


Home page
 J BiochemHome page
Y. Wei, D. Liu, Y. Ge, F. Zhou, J. Xu, H. Chen, J. Gu, and J. Jiang
Identification of E1AF as a Target Gene of E2F1-induced Apoptosis in Response to DNA Damage
J. Biochem., October 1, 2008; 144(4): 539 - 546.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Panchanathan, H. Xin, and D. Choubey
Disruption of Mutually Negative Regulatory Feedback Loop between Interferon-Inducible p202 Protein and the E2F Family of Transcription Factors in Lupus-Prone Mice
J. Immunol., May 1, 2008; 180(9): 5927 - 5934.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Y. Lee, Y. I. Choi, J. Kim, J. W. Choi, D. H. Sohn, C. Lee, S. H. Jeon, and R. H. Seong
Down-Regulation of the SWI/SNF Chromatin Remodeling Activity by TCR Signaling Is Required for Proper Thymocyte Maturation
J. Immunol., June 1, 2007; 178(11): 7088 - 7096.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Qiao, L. Di Stefano, C. Tian, Y.-Y. Li, Y.-H. Yin, X.-P. Qian, X.-W. Pang, Y. Li, M. A. McNutt, K. Helin, et al.
Human TFDP3, a Novel DP Protein, Inhibits DNA Binding and Transactivation by E2F
J. Biol. Chem., January 5, 2007; 282(1): 454 - 466.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
X. Lu, J. i. Jung, H. J. Cho, D. Y. Lim, H. S. Lee, H. S. Chun, D. Y. Kwon, and J. H. Park
Fisetin Inhibits the Activities of Cyclin-Dependent Kinases Leading to Cell Cycle Arrest in HT-29 Human Colon Cancer Cells
J. Nutr., December 1, 2005; 135(12): 2884 - 2890.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
Z. Li, J. Stanelle, C. Leurs, H. Hanenberg, and B. M. Putzer
Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library
Nucleic Acids Res., May 16, 2005; 33(9): 2813 - 2821.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Q. Cao, Y. Xia, M. Azadniv, and I. N. Crispe
The E2F-1 Transcription Factor Promotes Caspase-8 and Bid Expression, and Enhances Fas Signaling in T Cells
J. Immunol., July 15, 2004; 173(2): 1111 - 1117.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Scheijen, M. Bronk, T. van der Meer, D. De Jong, and R. Bernards
High Incidence of Thymic Epithelial Tumors in E2F2 Transgenic Mice
J. Biol. Chem., March 12, 2004; 279(11): 10476 - 10483.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. W. Verschuren, J. G. Hodgson, J. W. Gray, S. Kogan, N. Jones, and G. I. Evan
The Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis
Cancer Res., January 15, 2004; 64(2): 581 - 589.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
U. Ziebold, E. Y. Lee, R. T. Bronson, and J. A. Lees
E2F3 Loss Has Opposing Effects on Different pRB-Deficient Tumors, Resulting in Suppression of Pituitary Tumors but Metastasis of Medullary Thyroid Carcinomas
Mol. Cell. Biol., September 15, 2003; 23(18): 6542 - 6552.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. DeRyckere, D. L. Mann, and J. DeGregori
Characterization of Transcriptional Regulation During Negative Selection In Vivo
J. Immunol., July 15, 2003; 171(2): 802 - 811.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
F. X. Li, J. W. Zhu, C. J. Hogan, and J. DeGregori
Defective Gene Expression, S Phase Progression, and Maturation during Hematopoiesis in E2F1/E2F2 Mutant Mice
Mol. Cell. Biol., May 15, 2003; 23(10): 3607 - 3622.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. D. MUNDLE and G. SABERWAL
Evolving intricacies and implications of E2F1 regulation
FASEB J, April 1, 2003; 17(6): 569 - 574.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. E. Cloud, C. Rogers, T. L. Reza, U. Ziebold, J. R. Stone, M. H. Picard, A. M. Caron, R. T. Bronson, and J. A. Lees
Mutant Mouse Models Reveal the Relative Roles of E2F1 and E2F3 In Vivo
Mol. Cell. Biol., April 15, 2002; 22(8): 2663 - 2672.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. W. Zhu, S. J. Field, L. Gore, M. Thompson, H. Yang, Y. Fujiwara, R. D. Cardiff, M. Greenberg, S. H. Orkin, and J. DeGregori
E2F1 and E2F2 Determine Thresholds for Antigen-Induced T-Cell Proliferation and Suppress Tumorigenesis
Mol. Cell. Biol., December 15, 2001; 21(24): 8547 - 8564.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. J. A. D'Souza, A. Pajak, K. Balazsi, and L. Dagnino
Ca2+ and BMP-6 Signaling Regulate E2F during Epidermal Keratinocyte Differentiation
J. Biol. Chem., June 22, 2001; 276(26): 23531 - 23538.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2000 by the American Association of Cancer Research.